Collaborations
Besides conducting their own research, our faculty are involved
in a number of collaborations with various programs. These
include:
The
Johns Hopkins University General Clinical Research Center
This Center offers a Biostatistics and Computerized Data Management
and Analysis System (CDMAS) facility which provides support
to investigators related to protocol review, consultation, collaboration,
teaching, methodologic innovation and bridge building.
New Approaches to
Brain Tumor Therapy (NABTT) Consortium
The primary objective of the "New Approaches to Brain Tumor
Therapy (NABTT)" CNS Consortium is to improve the therapeutic
outcome for adults with primary brain tumors. This consortium
is one of two nationwide that is funded by the National Cancer Institute
to conduct Phase I and II clinical evaluations of promising new treatment
strategies (surgery, radiation, chemotherapy, and biologic therapies),
routes of administration, and clinical trial design in the treatment
of primary malignancies of the central nervous system.
NIDDK Biotechnologies
Consortium
The National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) has established a Biotechnologies Consortium to make comprehensive
gene expression technologies widely available to researchers working
in areas supported by the NIDDK. Biotechnology Centers will
provide genomic profiling resources to investigators working in research
areas within the NIDDK's mission.
Specialized
Programs of Research Excellence (SPORES)
In 1992, the NCI established the Specialized Programs of Research
Excellence (SPOREs) to promote interdisciplinary research and to
speed the bidirectional exchange between basic and clinical science
to move basic research finding from the laboratory to applied settings
involving patients and populations. Laboratory and clinical scientists
work collaboratively to plan, design and implement research programs
that impact on cancer prevention, detection, diagnosis, treatment
and control. Hopkins investigators participate in the following SPORE
programs: Breast
Cancer, Lymphoma, Lung
Cancer, Gastrointestinal
Cancer, Prostate
Cancer. |
